News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
743,756 Results
Type
Article (68315)
Company Profile (279)
Press Release (675162)
Multimedia
Podcasts (107)
Webinars (12)
Section
Business (205294)
Career Advice (3060)
Deals (36145)
Drug Delivery (119)
Drug Development (85674)
Employer Resources (173)
FDA (16811)
Job Trends (15749)
News (353713)
Policy (34597)
Tag
Academia (2926)
Academic (2)
Accelerated approval (6)
Adcomms (27)
Allergies (93)
Alliances (51793)
ALS (99)
Alzheimer's disease (1500)
Antibody-drug conjugate (ADC) (141)
Approvals (16786)
Artificial intelligence (292)
Autoimmune disease (27)
Automation (16)
Bankruptcy (336)
Best Places to Work (12212)
BIOSECURE Act (22)
Biosimilars (116)
Biotechnology (192)
Bladder cancer (84)
Brain cancer (31)
Breast cancer (294)
Cancer (2377)
Cardiovascular disease (200)
Career advice (2591)
Career pathing (34)
CAR-T (168)
Cell therapy (472)
Cervical cancer (21)
Clinical research (69258)
Collaboration (885)
Company closure (1)
Compensation (510)
Complete response letters (30)
COVID-19 (2807)
CRISPR (47)
C-suite (264)
Cystic fibrosis (107)
Data (2253)
Decentralized trials (2)
Denatured (37)
Depression (49)
Diabetes (297)
Diagnostics (6693)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (135)
Drug pricing (116)
Drug shortages (30)
Duchenne muscular dystrophy (99)
Earnings (79677)
Editorial (45)
Employer branding (21)
Employer resources (151)
Events (115426)
Executive appointments (771)
FDA (18125)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (797)
Gene editing (117)
Generative AI (30)
Gene therapy (344)
GLP-1 (838)
Government (5000)
Grass and pollen (6)
Guidances (66)
Healthcare (20076)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (144)
Indications (30)
Infectious disease (2964)
Inflammatory bowel disease (153)
Inflation Reduction Act (10)
Influenza (56)
Intellectual property (101)
Interviews (580)
IPO (16763)
IRA (45)
Job creations (3999)
Job search strategy (2165)
Kidney cancer (11)
Labor market (33)
Layoffs (539)
Leadership (24)
Legal (8221)
Liver cancer (80)
Lung cancer (338)
Lymphoma (154)
Machine learning (7)
Management (59)
Manufacturing (323)
MASH (73)
Medical device (13835)
Medtech (13840)
Mergers & acquisitions (19967)
Metabolic disorders (768)
Multiple sclerosis (87)
NASH (22)
Neurodegenerative disease (113)
Neuropsychiatric disorders (30)
Neuroscience (2088)
NextGen: Class of 2025 (7157)
Non-profit (4965)
Now hiring (21)
Obesity (410)
Opinion (267)
Ovarian cancer (76)
Pain (96)
Pancreatic cancer (84)
Parkinson's disease (161)
Partnered (22)
Patents (246)
Patient recruitment (115)
Peanut (51)
People (61811)
Pharmaceutical (68)
Pharmacy benefit managers (17)
Phase I (21421)
Phase II (30319)
Phase III (22721)
Pipeline (1236)
Policy (161)
Postmarket research (3061)
Preclinical (9430)
Press Release (70)
Prostate cancer (113)
Psychedelics (36)
Radiopharmaceuticals (264)
Rare diseases (429)
Real estate (6441)
Recruiting (69)
Regulatory (23637)
Reports (40)
Research institute (2608)
Resumes & cover letters (467)
Rett syndrome (5)
RNA editing (5)
RSV (48)
Schizophrenia (77)
Series A (142)
Series B (90)
Service/supplier (10)
Sickle cell disease (58)
Special edition (14)
Spinal muscular atrophy (162)
Sponsored (32)
Startups (3714)
State (1)
Stomach cancer (13)
Supply chain (73)
Tariffs (38)
The Weekly (68)
Vaccines (787)
Venture capitalists (42)
Weight loss (288)
Women's health (35)
Worklife (20)
Date
Today (4)
Last 7 days (921)
Last 30 days (2628)
Last 365 days (33844)
2025 (11286)
2024 (36332)
2023 (40853)
2022 (52106)
2021 (56970)
2020 (55865)
2019 (49441)
2018 (37526)
2017 (34407)
2016 (34444)
2015 (40180)
2014 (33918)
2013 (30058)
2012 (31630)
2011 (31441)
2010 (30425)
Location
Africa (1045)
Alabama (59)
Alaska (7)
Arizona (208)
Arkansas (14)
Asia (43741)
Australia (7704)
California (6184)
Canada (2012)
China (558)
Colorado (274)
Connecticut (293)
Delaware (151)
Europe (100845)
Florida (924)
Georgia (213)
Idaho (62)
Illinois (587)
India (27)
Indiana (314)
Iowa (9)
Japan (166)
Kansas (102)
Kentucky (26)
Louisiana (12)
Maine (64)
Maryland (931)
Massachusetts (4679)
Michigan (232)
Minnesota (380)
Mississippi (2)
Missouri (90)
Montana (30)
Nebraska (25)
Nevada (64)
New Hampshire (63)
New Jersey (1790)
New Mexico (31)
New York (1785)
North Carolina (1060)
North Dakota (8)
Northern California (2672)
Ohio (212)
Oklahoma (15)
Oregon (37)
Pennsylvania (1370)
Puerto Rico (11)
Rhode Island (32)
South America (1378)
South Carolina (22)
South Dakota (1)
Southern California (2328)
Tennessee (102)
Texas (921)
United States (23684)
Utah (185)
Virginia (157)
Washington D.C. (64)
Washington State (566)
West Virginia (3)
Wisconsin (61)
743,756 Results for "national institute of diabetes and digestive and kidney diseases niddk".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting
April 11, 2025
·
7 min read
Drug Development
Enable Biosciences Receives $3M Phase IIB SBIR Award from NIDDK for Advanced T1D Testing Technology
Enable Biosciences Inc. is elated to announce its receipt of a Phase IIB Small Business Innovation Research (SBIR) award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
December 19, 2023
·
2 min read
Press Releases
NIMML Institute to Present Novel Clinical and Translational Data of Omilancor in Ulcerative Colitis Patients at Digestive Disease Week 2025
April 10, 2025
·
2 min read
Press Releases
Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)
April 28, 2025
·
16 min read
Press Releases
Intercept Announces Data to be Presented at Digestive Disease Week 2025
April 30, 2025
·
15 min read
Press Releases
Boston Pharmaceuticals to Present State-of-the-Art Lecture and Poster for Once-monthly Efimosfermin Alfa at Digestive Disease Week® 2025
April 23, 2025
·
7 min read
Press Releases
Fujifilm Demonstrates State-of-the-Art Endoscopic Imaging Technology at the Digestive Disease Week (DDW®) 2025 Conference
April 30, 2025
·
5 min read
BioMidwest
Semaglutide Reduced Risk for Major Kidney Disease Events by 24% for Patients with Type 2 Diabetes and Kidney Disease
Findings from the landmark FLOW trial, the first dedicated kidney outcomes trial with a GLP-1 receptor agonist were reported, demonstrating semaglutide significantly reduces the risk of major kidney disease events and cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease.
June 24, 2024
·
4 min read
Press Releases
Feinstein Institutes Researchers Lead Successful Study Demonstrating Benefit to Patients With Lupus Kidney Disease
April 21, 2025
·
2 min read
Biotech Beach
National Institute of Health to Fund Preclinical Development of Trethera Lead Drug, TRE-515, for Treatment of Crohn’s Disease
Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today that it was awarded a Small Business Technology Transfer (STTR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) division of the National Institute of Health (NIH).
September 25, 2023
·
5 min read
1 of 74,376
Next
